Deoxyribonucleoside triphosphate pools in uninfected and herpes simplex virus type 1 (HSV-1)-and HSV-2-infected KB cells were analyzed to determine whether ribonucleotide reductase functions in vivo in the presence and absence of thymidine (TdR). Previously we showed that HSV-2 replication was inhibited in KB cells blocked in their capacity to synthesize DNA by TdR. HSV-1 replication was not inhibited under these conditions. Both HSV-1 and HSV-2 induced an altered ribonucleotide reductase resistant to dTTP inhibition. Thus, the block to HSV-2 replication apparently was not at the level of reductase. However, the in vitro activity of the enzyme does not necessarily correspond to intracellular conditions. In TdR-blocked HSV-2-infected cells, we found that, while dTTP levels remained high, dCTP concentrations increased. In contrast, KB cells blocked by TdR showed increased dTTP but decreased dCTP levels. We conclude that the HSV-2 enzyme is functional in vivo and that TdR inhibits viral replication by a mechanism other than depletion of dCTP. Infection of KB cells with HSV-1 or HSV-2 altered both dATP and dGTP levels in the presence or absence of TdR. Inhibition of viral replication was not explained by changes in these pools. We suggest that, during infection, HSV-1 induces a virus functions) not related to reductase which is resistant to TdR, whereas the corresponding HSV-2 function is sensitive. Our evidence shows that the TdR-sensitive function is not in the pathways leading to deoxyribonucleoside triphosphate and may occur at the level of DNA replication.
Deoxyribonucleoside triphosphate pools in uninfected and herpes simplex virus type 1 (HSV-1)-and HSV-2-infected KB cells were analyzed to determine whether ribonucleotide reductase functions in vivo in the presence and absence of thymidine (TdR). Previously we showed that HSV-2 replication was inhibited in KB cells blocked in their capacity to synthesize DNA by TdR. HSV-1 replication was not inhibited under these conditions. Both HSV-1 and HSV-2 induced an altered ribonucleotide reductase resistant to dTTP inhibition. Thus, the block to HSV-2 replication apparently was not at the level of reductase. However, the in vitro activity of the enzyme does not necessarily correspond to intracellular conditions. In TdR-blocked HSV-2-infected cells, we found that, while dTTP levels remained high, dCTP concentrations increased. In contrast, KB cells blocked by TdR showed increased dTTP but decreased dCTP levels. We conclude that the HSV-2 enzyme is functional in vivo and that TdR inhibits viral replication by a mechanism other than depletion of dCTP. Infection of KB cells with HSV-1 or HSV-2 altered both dATP and dGTP levels in the presence or absence of TdR. Inhibition of viral replication was not explained by changes in these pools. We suggest that, during infection, HSV-1 induces a virus functions) not related to reductase which is resistant to TdR, whereas the corresponding HSV-2 function is sensitive. Our evidence shows that the TdR-sensitive function is not in the pathways leading to deoxyribonucleoside triphosphate and may occur at the level of DNA replication.
Replication of herpes simplex virus type 1 (HSV-1) is unimpeded in KB cells in which DNA synthesis is inhibited by high levels of thymidine (TdR) (4) . In contrast, replication of HSV-2 is inhibited in TdR-blocked KB cells (5) . In the mammalian cell, TdR is converted to dTTP (1) , which acts in vitro as an allosteric inhibitor of ribonucleotide reductase (12, 13) . This enzyme is responsible for the production of deoxycytidine nucleotides from cytidylate. When reductase activity is inhibited, the cells become deficient in dCTP, and neither DNA synthesis nor cell division can take place (1). DNA synthesis is apparently controlled at the precursor level by the quantity and availability of nucleotides (1) .
Extracts of HSV-1-infected cells contain an altered ribonucleotide reductase that is insensitive in vitro to the effects of dTTP (4, 5) . Uninfected KB cells contain an enzyme that is highly sensitive to dTTP. Thus, it is possible that the failure of HSV-2 to replicate in the presence of TdR is due to a dTTP-sensitive re-58 ductase. However, a "new" reductase activity highly resistant to dTTP inhibition was demonstrated in HSV-2-infected cell extracts (5 (4, 5, 6) . Suspension cultures of KB cells were counted directly with a hemocytometer, and monolayer cultured cells were counted after they were removed from the plastic dishes with 0.25% trypsin.
Virus preparation and titration. The procedures used for the preparation of virus stocks of HSV-1 (strain HF) and HSV-2 (strain Savage), as well as the plaque assay, were described previously (4, 5) . For infection, we employed an input multiplicity of 25 PFU of HSV per cell.
Cell synchronization and infection. KB cells were synchronized by the double TdR block method (4, 5, 6) . In brief, randomly growing KB cells, in suspension or in plastic tissue culture dishes (60 mm), were treated with 2 mM TdR for 18 to 20 h. The suspension cells were washed free of TdR by centrifugation and were resuspended in fresh warmed medium to reverse the block. TdR was removed from the monolayer cells by aspiration of the medium. After addition of fresh medium, the cells were grown for 12 h, and then 2 mM TdR was added for a second period of 18 to 20 h. Cells were infected or mockinfected 1 h prior to reversal of the second TdR block. At the time of reversal, the uninfected and infected KB cells were divided into separate cultures in the presence or absence of TdR (4) . Similar results for cell synchronization and viral infection were obtained in KB cells grown either in suspension or monolayer culture.
DNA synthesis in synchronized cell cultures. Pulse-labeling experiments were carried out as previously described (4, 5), employing 0.2 1ACi of [3H]hypoxanthine per ml of medium. Methods for the separation of DNA from RNA, as well as the determination of radioactivity, were previously described (4, 5) .
Viral DNA was separated from cellular DNA by isopycnic centrifugation (4, 5) .
Determination of deoxyribonucleotide pools. We used two methods for measuring nucleotide pools: an enzymatic technique (method A) was used to measure dTTP, dGTP, and dATP; and long-term labeling with 32p, followed by chromatographic separation (method B), was used to measure all dNTP levels in cell extracts. We found that these two methods were comparable for the levels of dTTP and dGTP. dATP was difficult to separate from ATP by method B (19) , and dCTP was measured by method B only.
Method A. Measurement of pools by enzymatic methods. At different times prior to and after the reversal of the TdR block, samples of infected or uninfected KB cells in suspension were centrifuged at 800 x g for 5 min at 4 C. One milliliter of iced 0.5 M perchloric acid was added to the cell pellets (2 x 106 cells); the mixture was kept in ice 30 min and was then centrifuged. The acid-soluble fraction was made 0.05 M with respect to Tris-hydrochloride, pH 8.2, and neutralized with 4 M KOH. The salt precipitate was removed by centrifugation at 1,500 x g. The supernatant fluid was used for enzymatic nucleotide determination, following essentially the methods described by Lindberg and Skoog (8) and Skoog (17) . For the determination of dATP and dTTP, the standard reaction mixture contained the following components in a final volume of 0.1 ml: radioactive dNTP, 60 pmol; limiting dNTP, 0.5 to 10 pmol; DNA polymerase, 0.2 U; poly(dA-dT)-poly(dAdT), 4 nmol; Tris-hydrochloride buffer, pH 8. 2, 5 9mol; MgCl2, 0.5 jtmol. The mixture was incubated at 37 C for 35 min and chilled in ice. To each tube was added 0.1 ml of a mixture containing 6.4 ,umol of tetrasodium PPj, 4 j&mol of EDTA, and 1.5 mg of bovine serum albumin. One milliliter of 10% trichloroacetic acid was added, and the tubes were kept in ice for 15 min. The precipitates were collected on Whatman GF/A filters premoistened with 0.1 M tetrasodium PPj. The filters were dried, and the radioactivity was counted in Formula 949 (New England Nuclear Corp.). The assay for dGTP was essentially the same as described above, using poly(dI-dC)-poly(dI-dC) as template, except that the standard curve was saturated at 5 pmol of dGTP.
The enzymatic assay for dCTP was essentially the same as described above, except that it was necessary to increase the amount of Tris buffer to 25 ,umol and to incubate the sample at 37 C for 1 h. Although the assay conditions for measuring dCTP were adequate, we have been unable to measure the level of dCTP in infected or uninfected cell extracts. This is apparently due to the presence of an inhibitor in the extracts. The inhibitor appears to be present in extracts prepared by the perchloric acid-potassium hydroxide method, as well as by the methanol method (17) . In attempting to apply the assay to cell extracts, we varied the concentration of enzyme, template, MgCl2, Tris buffer, and bovine serum albumin. We also varied incubation time and temperature. However, we could not measure dCTP reproducibly in cell extracts.
The amounts of dNTP were calculated by the method of Munch-Petersen et al. (9) . This calculation accounts for changes in the specific activity of the labeled excess dNTP due to the presence of that dNTP in the cell extracts. dNTP concentrations are expressed on a per cell basis, rather than by the amount of DNA present, so that pools in infected and uninfected cells can be more easily compared.
Each point represents the average of triplicate samples.
Method B. 32p equilibrium labeling. Measurement of pools by 32p labeling was performed as previously described (14, 15) . Briefly, monolayers of randomly growing KB cells were labeled with 32p (2 .uCi/ml of medium) 1 day prior to the start of the double TdR block. 32p was present in the medium throughout the TdR block. At different times following reversal, the medium was removed and the cells were cooled to 4 C. One milliliter of 0.5 M perchloric acid was added to the monolayers, and the acidsoluble extract was treated as described above.
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To separate ribonucleoside triphosphates and dNTP's, samples of the neutralized acid extracts were mixed with 10 ,umol of known triphosphates and spotted on polyethyleneimine cellulose thin layers (Baker-flex, Baker Chemical Co., Phillipsburg, N.J.). The chromatograms were developed by the method of Neuhard et al. (10) . The position of the radioactive spots, as determined by radioautography, was matched with the position of carrier nucleotides located by UV light. The spots were cut out of the thin-layer chromatogram and were counted for radioactivity in Formula 949 (New England Nuclear Corp. (Fig. 1B) in mockinfected KB cells was minimal. Two hours after the cells were washed free of TdR, the intracellular concentration of dTTP decreased to less than 250 pmol/106 cells. Cellular DNA synthesis began by 2 h after reversal.
After infection with HSV-1 (Fig. 1C) , the level of dTTP decreased in infected cells incubated in the presence or absence of TdR. However, this concentration of dTTP was still threefold higher in cells infected in the presence of TdR than in cells infected in its absence. The rates of DNA synthesis in HSV-1-infected cultures (Fig. 1D) were not affected by the presence of TdR. New viral DNA was detected 3 to 4 h after infection, and new progeny virus was detected between 6 and 8 h. The progeny virus titers were essentially the same, regardless of the presence or absence of TdR in the culture medium. These results are in agreement with previous observations (4, 5) .
In HSV-2-infected cultures, the level of dTTP (Fig. 1E ) declined after TdR was removed, in a manner similar to that observed with HSV-1 (Fig. 10) . The rate of DNA synthesis (Fig. 1F) increased by 2 h, new HSV-2 DNA was detected by 4 to 6 h, and new virus was detected by 8 to 10 h postinfection. However, when cells were infected with HSV-2 in the presence of TdR, the intracellular level of dTTP (Fig. 1E) did not decrease as dramatically as it did when TdR was absent. By 4 h after infection, the intracellular dTTP level was approximately five times higher when TdR was present than when it was absent. This dTTP concentration was also 15 times higher than that seen in reversed KB cells (Fig. 1A) and approximately the same as the dTTP level found in blocked cells prior to reversal. HSV-2 DNA synthesis was markedly inhibited in the presence of TdR, and under these conditions there was no increase in virus production.
(ii) dCTP. The data in Fig. 2 answer the critical question concerning the effect of TdR on dCTP pools in infected and uninfected cells. Figure 2A shows that TdR-blocked KB cells contained low levels of dCTP (less than 50 pmol/106 cells). When KB cells were reversed, the dCTP level increased. By 8 h after reversal, the dCTP level was 16-fold higher in these cells than in the TdR-blocked controls. These data show that, when cells contained high concentrations of dTTP, the levels of dCTP were minimal. Thus, reversal of the TdR block resulted in a rapid decrease in dTTP concentration and an increase in dCTP level at the time of or preceding the onset of KB DNA synthesis. These results are similar to those reported by Bjursell and Reichard for Chinese hamster ovary cells (1) .
When HSV-1-infected cells were incubated in the presence or absence of TdR (Fig. 2B) , the concentration of dCTP increased by 3 h postinfection. In HSV-2-infected cells (Fig. 2C) , the intracellular concentration of dCTP also increased in the presence or absence of TdR. Thus, it appears that the altered ribonucleotide reductase observed in HSV-1-and HSV-2-infected cells is capable of reducing cytidylate to deoxycytidylate in the presence of high concentrations of TdR, not only in vitro but also in vivo. However, when TdR was present, synthesis of HSV-2 DNA and progeny virus was inhibited. Therefore, the mechanism by which 18, 1976 TdR blocks HSV-2 replication appears to differ from the mechanism by which TdR inhibits mammalian cell division.
(iii) dATP. Next we determined whether high dTTP levels would raise dATP to inhibitory concentrations in HSV-2-infected cells. Deoxyadenosine triphosphate is a general negative allosteric inhibitor of ribonucleotide reductase (12) and may be part of the mechanism by which deoxyadenosine inhibits HSV replication (2) . The levels of dATP in KB cells (Fig.  3A) appeared to increase approximately fourfold over the course of the cell cycle. No significant difference in the level of dATP was observed when KB cells were incubated in the presence or absence of TdR. Infection with HSV-1 (Fig. 3B) or HSV-2 (Fig. 3C) ) showed an increase in dATP after infection with HSV-1 and, in contrast, Jamieson and Bjursell (J. Gen. Virol., in press) showed a decrease. We have no explanation for this difference.
(iv) dGTP. The next possibility was that the block to HSV-2 replication might be due to changes in dGTP concentration. Jamieson and Bjursell (J. Gen. Virol., in press) have found that in HSV-1-infected cells, the dGTP level increases in the presence of a greatly increased dTTP level. Figure 4A shows that, within 4 h after TdR was removed from uninfected KB cells, the level of dGTP was reduced fivefold. However, the levels of dGTP were unchanged in KB cells maintained in the presence of TdR. These observations are consistent with the in vitro action of dTTP as a positive allosteric effector of ribonucleotide reductase for the production of dGTP (1) . After infection with either HSV-1 or HSV-2 ( Fig. 4B and C) , there was an increase in the level of dGTP in the presence or absence of TdR over the infectious cycle. By 10 h after reversal, the dGTP levels in infected cells were 8-to 15-fold higher than in the uninfected KB cells. Moreover, the dGTP level reached a higher level in the presence of TdR than in its absence.
DISCUSSION
The current experiments were performed to determine whether ribonucleotide reductase functions in HSV-2-infected cells in the presence of TdR. Previous experiments showed that HSV-2 induced an altered ribonucleotide reductase in extracts of KB cells (5) . This enzyme, like the HSV-1-induced enzyme, was found to be insensitive to inhibition by dTTP (4). Although these earlier observations suggested that the block to HSV-2 replication was not at the level of ribonucleotide reductase, the possibility existed that the in vitro activity did not necessarily correspond to the intracellular conditions. We reasoned that the capacity of this enzyme to function in vivo should be reflected by the appearance of dCTP in the dNTP pools. Therefore, we characterized the levels of dNTP in infected and uninfected KB cells. In TdRblocked HSV-2-infected KB cells, the level of dTTP remained high and the level of dCTP increased. Under these conditions, viral DNA synthesis and formation of progeny virus were inhibited. We conclude that the virus-induced ribonucleotide reductase is functional in vivo in the presence of dTTP and that TdR inhibits HSV-2 replication by a mechanism other than depletion of dCTP pools. One caveat to this conclusion is that we do not know whether the dCTP pool found in TdR-blocked HSV-2-infected cells is available for DNA synthesis. Skoog and Bjursell (18) have shown that dNTP's are compartmentalized in the nucleus and the cytoplasm and that distribution varies during the cell cycle (18) . The fact that dCTP is synthesized in HSV-2-infected cells in the presence of TdR may explain why the addition of deoxycytidine to infected cells fails to reverse TdR inhibition (4, 7, 10; Cohen and Roller, unpublished data). In contrast, when deoxycytidine is added to TdR-blocked mammalian cells, DNA synthesis resumes (1) .
Inhibition of HSV-2 replication, thus, appears to occur by a different mechanism than that operating in the cell. Excess TdR acts on the KB cell to increase dTTP levels, markedly decrease dCTP levels, and inhibit host cell DNA synthesis. When TdR was removed from the medium, the dTTP level decreased, the level of dCTP increased, and DNA synthesis was initiated. These results in KB cells are consistent with the effects of TdR on dNTP pools and DNA synthesis in Chinese hamster ovary cells (1) . We postulated earlier that the HSV-1-induced reductase allows the virus to override the TdR block by synthesis of dCTP. The fact that the intracellular level of dCTP increased dramatically in HSV-1-infected cells, even in the presence of elevated levels of dTTP, suggests that the virus-induced ribonucleotide reductase functions to reduce cytidylate both in vivo and in vitro. Thus, infection by either HSV-1 or HSV-2 results in the production of a "new" ribonucleotide reductase and, in both cases, high levels of dCTP are produced in the presence of high concentrations of TdR.
Still it appears that a basic biochemical difference exists in the replication of the two forms of HSV. We suggest that, during replication, HSV-1 induces a virus-specific functions) not related to ribonucleotide reductase that is resistant to the effects of TdR. The corresponding HSV-2 function is sensitive to this nucleoside or derivative. Our evidence shows that the TdRsensitive function is not in the pathway leading to deoxynucleotide triphosphates and may occur at the level of DNA replication. We must also consider the alternative that the TdR-sensitive function is not directed by HSV-2, but is host specific and is required for DNA replication by type 2 virus but not by HSV-1. We suggested previously that HSV-2 may be similar to equine herpesvirus and may be dependent upon some phase of the cell cycle (5) . However, we found that HSV-2 replication, like that of HSV-1 (6) , is independent of the KB cell cycle (Cohen and Ponce de Leon, unpublished data). The possibility of another required host function still exists. Recently, Powell and Courtney (11) presented evidence that suggested that a labile host cell factor was required for herpesvirus protein synthesis. Future studies will be directed at efforts to determine the mechanism by which TdR inhibits HSV-2 replication.
